Xeomin 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FG1BP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,462
Award facts
- Contract value 100% obligated
- $49,461.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,461.72 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic purposes. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, with an ultimate completion date of December 5, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's relationship with DLA spans multiple therapeutic domains and demonstrates consistent capability to fulfill competitive federal procurement requirements. This delivery order for Xeomin reflects the company's role in supporting Defense Health Agency medical supply needs as part of the broader DLA Pharmaceutical Prime Vendor Global Program, which leverages flexible contract vehicles to ensure pharmaceutical availability across military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FG1BP?
SPE2DR26FG1BP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FG1BP worth?
The government has obligated $49,462 on SPE2DR26FG1BP.
Is contract SPE2DR26FG1BP an order under another contract?
Yes. SPE2DR26FG1BP is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1BP competed?
The extent of competition for SPE2DR26FG1BP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award